Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion
Different Regimens of Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion: a Randomized and Controlled Clinical Study.
Sponsor: Sun Yat-sen University
A PHASE4 clinical study on Photocoagulation Burn to Retina and Ranibizumab, this trial is ongoing. The trial is conducted by Sun Yat-sen University and has accumulated 5 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Nov 2022 — Jul 2024 [monthly]
Unknown Status PHASE4
Status: Not Yet Recruiting → Unknown Status
-
Jan 2021 — Nov 2022 [monthly]
Not Yet Recruiting PHASE4
-
Sep 2019 — Jan 2021 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Sun Yat-sen University
For direct contact, visit the study record on ClinicalTrials.gov .